XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Note 10 - Capital Stock and Stock-based Compensation
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Shareholders' Equity and Share-Based Payments [Text Block]

10.

Capital Stock and Stock-Based Compensation

 

Stock-Based Payment Awards

 

Stock-based awards consist of stock options, time-based restricted stock units, market condition restricted stock units, and shares issued under the Company’s employee stock purchase plan. Activity under the Company’s equity incentive plans for the nine months ended September 30, 2023 is as follows: 

 

      

Weighted

          

Market

     
      

Average

          

Condition

     
  

Stock

  

Exercise

  

Restricted

  

Grant Date

  

Restricted

  

Grant Date

 
  

Options

  

Price

  

Stock Units

  

Fair Value

  

Stock Units

  

Fair Value

 

Balance at December 31, 2022

  1,238,776  $3.15   1,093,801  $3.94   646,235  $4.51 

Granted

  -   -   1,306,445   2.82   558,958   2.61 

Exercised

  (213,644)  2.38   -   -   -   - 

Vested (RSUs)

  -   -   (295,531)  2.97   (115,976)  2.98 

Cancelled/Forfeited

  (101,065)  2.47   (86,440)  3.90   (87,138)  4.64 

Balance at September 30, 2023

  924,067   3.37   2,018,275   3.36   1,002,079   3.62 

 

 

Stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 is allocated as follows:

 

  

Three Months Ended September 30,

  

Nine Months Ended September 30,

 

(in thousands)

 

2023

  

2022

  

2023

  

2022

 

Cost of revenues

 $58  $-  $222  $88 

Sales and marketing expenses

  193   147   533   493 

General and administrative expenses

  1,012   919   2,585   2,633 

Research and development expenses

  100   73   278   187 

Total stock-based compensation expenses

 $1,363  $1,139  $3,618  $3,401 

 

As of September 30, 2023, the total compensation costs related to unvested awards not yet recognized is $6.0 million and the weighted average period over which it is expected to be recognized is approximately 1.7 years. The Company did not capitalize any stock-based compensation during the three and nine month periods ended September 30, 2023.

 

The weighted average estimated fair value of the market condition restricted stock awards that were granted during the nine months ended September 30, 2023 was $2.61 per unit. The estimate of the fair value was determined using a Monte-Carlo valuation simulation, which included the following assumptions:

 

Volatility

  56.8

%

Risk-free interest rate

  4.6

%

Correlation coefficient

  41.7

%

Dividend yield

  -

%

 

Earnings (Loss) Per Share

 

Basic earnings (loss) per share (EPS) is calculated by dividing net income (loss) by the number of weighted average shares of common stock outstanding during the period. The calculation of diluted earnings per share assumes conversion of stock options and restricted stock units into common stock using the treasury method. The weighted average number of shares used to compute basic and diluted EPS consisted of the following:

 

  

Three Months Ended September 30,

  

Nine Months Ended September 30,

 

(in thousands, except per share data)

 

2023

  

2022

  

2023

  

2022

 

Net loss available to common stockholders

 $(1,239) $(3,405) $(1,597) $(7,850)

Weighted average shares outstanding - basic

  42,688   41,637   42,345   41,353 

Dilutive effect of equity awards

  -   -   -   - 

Weighted average shares outstanding - diluted

  42,688   41,637   42,345   41,353 

Basic loss per share

 $(0.03) $(0.08) $(0.04) $(0.19)

Diluted loss per share

 $(0.03) $(0.08) $(0.04) $(0.19)

Shares excluded from diluted loss per share due to their anti-dilutive effect

  3,952   3,594   3,847   3,676